Related Experiment Videos
A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy
Cancer
|September 1, 1979
Abstract:
Cyclophosphamide is used extensively to treat malignancies. A 5-year-old boy with stage IV neuroblastoma is described who developed a fatal syndrome of inappropriate antidiuretic hormone (ADH) secretion after high dose cyclophosphamide therapy.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Envision the future of precision medicine in pediatric cancer.
Cancer cell·2024
Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury.
Science (New York, N.Y.)·2021
Pharmacologycal activity of peperina (Minthostachys verticillata) on gastrointestinal tract.
Journal of ethnopharmacology·2020
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.
Molecular and cellular biology·2026
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
Journal of the Association of Genetic Technologists·2026
Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.
Molecular cancer therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026